Follicle growth in the ovary is controlled by multiple factors and physiological events. While follicle-stimulating hormone (FSH) and luteinizing hormone (LH) are known to regulate the growth of antral follicles, the regulation of early stages of follicle growth is complex and unclear \[[@r1],[@r2],[@r3]\]. The early stage in follicle growth is independent of FSH and LH and controlled by many factors such as the kit ligand, growth differentiation factor 9 (GDF-9), leukemia inhibitor factor (LIF), insulin-like growth factor 1 (IGF-1), and bone morphogenetic protein-4 (BMP-4) \[[@r4], [@r5], [@r6], [@r7], [@r8], [@r9], [@r10], [@r11]\]. The development of follicles in the ovary is regulated by several mechanisms; understanding of these mechanisms necessitates simultaneous observation of the growth dynamics of various follicles. Our previous study reported a new method for culturing mouse ovarian tissue to observe the dynamics of follicle growth \[[@r11]\]. This method allows simultaneous observation of dynamics of many follicles to evaluate the effect of a given factor at the tissue level. In this study, we focused on the effect of progesterone (P~4~) on follicle growth in the mouse ovary.

Follicles and corpus luteum (CL) in the ovary synthesize and secrete P~4~ \[[@r12], [@r13]\]. P~4~ is involved in the maintenance of pregnancy and controls follicle growth and ovulation \[[@r14],[@r15],[@r16],[@r17],[@r18]\]. The progesterone receptor (PGR) is a nuclear receptor that is temporally expressed on granulosa cells of Graafian follicles during the periovulatory period \[[@r19], [@r20]\]. Ovulation is inhibited in mutant mice lacking functional PGR and in mice treated with PGR antagonist. Thus, P~4~-mediated stimulation of the PGR on granulosa cells is essential for ovulation \[[@r21],[@r22],[@r23],[@r24]\]. Granulosa cells contain other progesterone-binding proteins, one of which is the PGR membrane component 1 (PGRMC1) \[[@r18]\]. PGRMC1 binds P~4~ with high affinity and mediates anti-mitotic and anti-apoptosis functions of P~4~ in granulosa cells \[[@r25],[@r26],[@r27],[@r28]\]. The effect of P~4~ on follicles in the ovary varies with the presence of these binding proteins.

The concentration of P~4~ in blood changes during the estrus cycle \[[@r29]\]. This change affects ovarian dynamics, follicle growth, ovulation, CL formation, and pregnancy. We hypothesized that P~4~ may play an important role in the regulation of follicle growth at tissue level. Changes in serum P~4~ concentration occur at three stages: phase 1, before ovulation; phase 2, periovulation; and phase 3, pregnant period. The concentration of P~4~ in blood transiently increases during phase 2 and is the highest during phase 3 \[[@r29]\]. We tested our hypothesis by treating cultured mouse ovarian tissues with different concentrations of P~4~ (10 ng/ml, 100 ng/ml, and 1 μg/ml) and analyzed the effect of P~4~ on follicle growth \[[@r11]\]. Our study revealed new effects of P~4~ on the follicle growth and ovulation at tissue level.

Materials and Methods {#s1}
=====================

Animals
-------

Ovaries were isolated from 4-week-old female ICR mice (Japan SLC, Shizuoka, Japan). Mice were housed in an environmentally controlled room maintained at 23 ± 1°C with a 12-h light/12-h dark cycle. Animal care and experiments were conducted in accordance with the Guidelines for Animal Experimentation of Aichi Medical University. Experiments in this study were approved by The Animal Care and Use Committee of Aichi Medical University.

Culture of ovarian tissue
-------------------------

Ovaries from 4-week-old mice were sliced at a thickness of several hundred micrometers using a microtome blade (Leica Biosystems, Nussloch, Germany) under a stereoscopic microscope (Leica Biosystems). Ovarian tissue slices were placed in a 30-mm cell culture insert (Merck Millipore, Darmstadt, Germany), which was subsequently placed in a 3.5-cm culture dish (AGC Techno Glass, Shizuoka, Japan). Ovarian slices were cultured in the minimum essential medium alpha (MEM-alpha) GlutaMax (Gibco, Carlsbad, CA, USA) supplemented with 5% (v/v) fetal bovine serum (FBS, Gibco), 100 mIU/ml FSH from human pituitary gland (Sigma-Aldrich, St Louis, MO, USA), and 10 mIU/ml LH from equine pituitary gland (Sigma-Aldrich) under conditions of 5% CO~2~ and 37°C. The cultured ovarian tissue slices were treated with 100 mIU/ml of LH for 12 h every 4 days to reproduce the physiological LH surge. Concentrations of FSH and LH used were based on previous experiments \[[@r10], [@r11]\]. The effect of P~4~ on follicle growth was evaluated after adding P~4~ (10 ng/ml, 100 ng/ml, and 1 μg/ml) (Sigma-Aldrich) to the culture medium, followed by culture for 18 days. In this experiment, one ovary was cut into four slices; two of these slices were treated with dimethyl sulfoxide (DMSO) alone and the other two, with P~4~ dissolved in DMSO. Four or five ovaries were cultured with each concentration of P~4~.

Imaging of cultured ovarian slices
----------------------------------

Cultured ovarian slices were imaged at intervals of 24 h using a confocal microscope (LSM 710, Carl Zeiss Microimaging, Oberkochen, Germany), with a Z-step size of 5 μm and Z-stack thickness approximately 150 μm.

Analysis of follicle growth in cultured ovarian tissue slices
-------------------------------------------------------------

The area of each follicle observed in cultured ovarian tissue slices was measured using ImageJ software (<http://rsbweb.nih.gov/ij/>). The outline of the follicle in captured images was traced with a tablet pen (Intuos, Wacom, Saitama, Japan); the number of pixels in each follicle was measured and converted into area (μm^2^). The follicle area was measured at 24-h intervals to track follicle growth in cultured ovarian tissue slices. The development of follicles was classified into three stages ---primordial-primary, secondary, and antral--- based on their area on culture day 1. In the previous experiment, we observed cultured ovaries using Hoechst staining and counted the number of granulosa cell layer of each follicle. We classified the follicle stage based on the number of granulosa cell layer and measured the area of follicles. Based on these results, we established the criteria for the classification of follicles based on the area. The detailed information is presented in our previous report \[[@r11]\].

Measurement of 17β-estradiol in the cultured ovary and culture medium
---------------------------------------------------------------------

After sliced ovaries were cultured for 2 days, P~4~ (100 ng/ml) was added into the culture medium; equal volume of DMSO was used as a control. Following incubation for 12 and 24 h, cultured ovaries and the culture medium were collected. The right and left ovary from the same mouse was used as the control and test (P~4~-treated), respectively. Proteins from the ovary tissue were extracted using Tissue Extraction Reagent I (Invitrogen, Carlsbad, CA, USA) containing protease inhibitor cocktail (Clontech, Mountain View, CA, USA). The concentration of 17β-estradiol in the ovary extract and culture medium was measured using 17β-estradiol high-sensitivity enzyme-linked immunosorbent assay (ELISA) kit (Enzo Life Science, Farmingdale, NY, USA) following the manufacturer's protocol. Three ovaries were cultured in each condition and used in this experiment.

Staining of ovarian sections for PGRMC1
---------------------------------------

Ovaries of 4-week-old female mice were fixed with SUPER FIX (KURABO, Osaka, Japan) and embedded in paraffin. The embedded ovary was sliced into 6-μm thick serial sections. Endogenous peroxidase activity was blocked by treatment with 0.6% hydrogen peroxide/methanol at room temperature for 40 min. Sections were treated with anti-PGRMC1 antibody (2 μg/ml; Abcam, Cambridge, UK) or rabbit IgG (2 μg/ml; Vector Laboratories, Burlingame, CA, USA) and subjected to immunoperoxidase staining using the VECTASTAIN ABC Kit (Vector Laboratories) according to the standard protocol. All sections were counterstained with hematoxylin (MUTO PURE CHEMICALS, Tokyo, Japan).

Measurement of progesterone in serum of mice
--------------------------------------------

The estrus cycle of female mice was checked by vaginal smear method at 0900 h and 50 μl blood at proestrus, estrus, metestrus, diestrus, and pregnant day 7 was collected from the caudal vein of the mouse at 1700 h. Blood serum was collected by centrifugation at 25,000 × *g* for 10 min at 4°C. The concentration of P~4~ in the serum of three mice at each stage was measured using Progesterone ELISA kit (Enzo Life Science) following the manufacturer's protocol.

Statistical analyses
--------------------

Statistical analyses were performed using the software R (<http://www.r-project.org/>). First, the normality of all data was evaluated using the Shapiro-Wilk normality test (P \< 0.05). We then analyzed the normally distributed data using the unpaired *t*-test/one-way analysis of variance ([Figs. 2](#fig_002){ref-type="fig"},[3](#fig_003){ref-type="fig"},[4](#fig_004){ref-type="fig"} and[6](#fig_006){ref-type="fig"}Fig. 1.Images of the cultured ovaries. Images of cultured ovaries of culture day 1 and culture day 14 are presented. Except the cultured ovary containing 1 μg/ml P~4~, each cultured ovary ovulated some oocytes before culture day 14. Scale bar: 200 μm.Fig. 2.Tracking follicle growth in the cultured ovary. Change in the average follicle area within the cultured ovary. Panels A, B and C: area of primordial-primary follicles. Panels D, E and F: area of secondary follicles. Panels G, H and I: area of antral follicles. Panels A, D and G: control and follicles treated with 10 ng/ml P~4~. Panels B, E and H: control and follicles treated with 100 ng/ml P~4~. Panels C, F and I: control and follicles treated with 1 μg/ml P~4~. Black circles and lines, control; black squares and dash lines, follicles treated with P~4~. Data are presented as the mean ± SD. \* P \< 0.05; \*\* P \< 0.01.) and non-normally distributed data using the Mann-Whitney U test ([Fig. 2](#fig_002){ref-type="fig"}). The normality of the data for follicular area differed between the culture days, the test chosen (unpaired *t*-test/one-way ANOVA, or Mann‑Whitney U test) ([Fig. 2](#fig_002){ref-type="fig"}).

Results {#s2}
=======

The effect of progesterone on follicle growth in the ovary
----------------------------------------------------------

We determined the effect of P~4~ on follicle growth in the ovary by adding P~4~ to the culture medium at 10 ng/ml, 100 ng/ml, and 1 μg/ml concentrations ([Fig. 1](#fig_001){ref-type="fig"}). These P~4~ concentrations reproduced the change in blood P~4~ concentration during estrus cycle. We analyzed the effect of each P~4~ concentration by tracking the growth of each follicle in the cultured ovary during 18 days in culture. We measured the follicle area at 24-h intervals as the index of follicle growth ([Fig. 2](#fig_002){ref-type="fig"}). Based on the area of each follicle on culture day 1, the growth of follicle was divided into three stages as follows: primordial-primary follicle, \< 3000 μm^2^; secondary follicle, 3000--10000 μm^2^; antral follicle, \> 10000 μm^2^ ([Fig. 2](#fig_002){ref-type="fig"}). Details of follicle classification were described in our previous report \[[@r11]\]. At 10 ng/ml, P~4~ showed no effect on follicle growth ([Fig. 2A, D, and G](#fig_002){ref-type="fig"}). While P~4~ promoted growth of primordial-primary follicles at 100 ng/ml ([Fig. 2B](#fig_002){ref-type="fig"}), it suppressed the growth of secondary follicles at 1 μg/ml ([Fig. 2F](#fig_002){ref-type="fig"}). At 100 ng/ml and 1 μg/ml, P~4~ exhibited no effect on other follicle stages ([Fig. 2C, E, H and I](#fig_002){ref-type="fig"}). Significant differences were observed in the growth of secondary and antral follicles between 10 and 100 ng/ml P~4~ at some time points ([Fig. 2D, E and G](#fig_002){ref-type="fig"}). At these time points, some of the follicles ovulated or degenerated and hence were excluded from the measurement, thereby decreasing the average follicle area. Therefore, these significant differences are not contributed by the effect of P~4~ on follicle growth. In addition, we cultured ovarian tissues in presence of 10 μg/ml P~4~, but its effect on the follicle growth and ovulation was same as seen with 1 μg/ml P~4~ (data not shown). These results indicate that the effect of P~4~ on follicle growth is dependent on its concentration.

The effect of progesterone on ovulation
---------------------------------------

During the 18-day culture period, we counted the number of ovulated oocytes in the culture medium at each P~4~ concentration ([Fig. 3](#fig_003){ref-type="fig"}Fig. 3.The number of ovulated oocytes during the culture period. Black bars, control; gray bars, ovaries treated with P~4~. C: control, P~4~: progesterone. 10 ng/ml, 100 ng/ml, and 1 μg/ml: concentrations of P~4~. Data are presented as the mean ± SD. \* P \< 0.05.). At 100 ng/ml, P~4~ significantly increased the average number of ovulated oocytes (control, 6 oocytes; 100 ng/ml P~4~, 10.8 oocytes). On the other hand, P~4~ treatment at 1 μg/ml concentration tended to decrease the number of ovulated oocytes (control, 6 oocytes; 1 μg/ml P~4~, 2.8 oocytes; no significant difference, P = 0.12). At 10 ng/ml, P~4~ showed no effect on ovulation (control, 6.3 oocytes; 10 ng/ml P~4~, 5.5 oocytes).

The effect of progesterone on the concentration of 17β-estradiol in the cultured tissue and culture medium
----------------------------------------------------------------------------------------------------------

Progesterone is converted to 17β-estradiol in follicles. Thus, the growth of follicles and process of ovulation may be promoted by P~4~ either directly or through 17β-estradiol. We measured the concentration of 17β-estradiol in the cultured ovary and culture medium with ELISA. The concentration of 17β-estradiol recorded was as follows: cultured ovary of a 12-h culture, P~4~(--): 255.5 ± 6.3 pg/ml, P~4~(+): 252 ± 13.0 pg/ml; culture medium of a 12-h culture, P~4~(--): 30.0 ± 7.0 pg/ml, P~4~(+): 27.3 ± 3.8 pg/ml; cultured ovary of a 24-h culture, P~4~(--): 276.8 ± 33.8 pg/ml, P~4~(+): 283.1 ± 7.1 pg/ml; and culture medium of a 24-h culture, P~4~(--): 33.9 ± 5.1 pg/ml, P~4~(+): 38.3 ± 17.0 pg/ml ([Fig. 4](#fig_004){ref-type="fig"}Fig. 4.The concentration of 17β-estradiol in the cultured ovaries and the culture medium. Comparison of the concentration of 17β-estradiol between normal culture condition and treatment group with P~4~. 12 h and 24 h indicate the time of treatment with DMSO (control) or P~4~. Black bar: control group, gray bar: treatment group with P~4~. There was no significant difference between each control and treatment group. Data are presented as the mean ± SD.). P~4~ exhibited no effect on the concentration of 17β-estradiol in the cultured ovary and culture medium, indicative of its direct action on the follicle growth.

The expression of PGRMC1 in follicles
-------------------------------------

Progesterone receptors are expressed in Graafian follicles only during the periovulatory period. We, therefore, evaluated the expression of PGRMC1 in follicles ([Fig. 5](#fig_005){ref-type="fig"}Fig. 5.Immunohistochemistry of PGRMC1 in mouse ovary. Panels A and B, C and D, and E and F are images of adjacent mouse ovary sections. Panels A, C and D: stained with anti-PGRMC1 antibody. Panels B, D and F: stained with rabbit IgG. Panel A: arrows, primordial follicles expressing PGRMC1 in granulosa cells; arrowheads, primordial follicles without PGRMC1 expression. Panel C: arrows, primary follicles expressing PGRMC1 in granulosa cells; Panel D: arrows, same follicles indicated in panel C. Panel E and F: \* secondary follicle; \*\* antral follicle expressing PGRMC1 in granulosa cells. Scale bar: 50 μm.). The expression of PGRMC1 was detected in granulosa cells of some primordial follicles ([Fig. 5A](#fig_005){ref-type="fig"}) and all of the primary, secondary, and antral follicles ([Fig. 5C and E](#fig_005){ref-type="fig"}). The level of expression increased with the growth of follicles. Staining with rabbit IgG revealed weak signals in granulosa cells of secondary and antral follicles ([Fig. 5D and F](#fig_005){ref-type="fig"}); however, these signals were much weaker than those recorded with anti-PGRMC1 antibody ([Fig. 5C--F](#fig_005){ref-type="fig"}). As shown in [Figs. 5](#fig_005){ref-type="fig"}C and D, the expression of PGRMC1 was detected in granulosa cells of secondary and antral follicles. In addition, the expression of PGRMC1 was detected in ovarian surface cells and some stromal cells ([Fig. 5A](#fig_005){ref-type="fig"}).

The change in the concentration of P~4~ in mouse blood during estrus cycle and pregnancy
----------------------------------------------------------------------------------------

In the cultured ovary, the effect of P~4~ was concentration dependent. We investigated the change in the concentration of P~4~ in the mouse blood by measuring the serum concentration of P~4~ at each estrus stage and pregnant day 7. The concentration of P~4~ detected at each stage was as follows: proestrus, 8.7 ± 1.7 ng/ml; estrus, 10.1 ± 2.3 ng/ml; metestrus, undetected; diestrus, undetected; and pregnant day 7, 10.2 ± 1.8 ng/ml ([Fig. 6](#fig_006){ref-type="fig"}Fig. 6.The concentration of P~4~ in the serum of mouse during estrus cycle and pregnancy. The change in the concentration of P~4~ in the serum of mouse during estrus cycle. The concentration of P~4~ at metestrus and diestrus was undetected in this experiment; therefore, the concentration at these stages was presented as 0 ng/ml in this graph. There was no significant difference between proestrus, estrus, and pregnant day 7. There was significant difference between metestrus/diestrus and other stages (P \< 0.01). Data are presented as the mean ± SD.). The level of P~4~ at proestrus, estrus, and pregnant day 7 was almost similar. On the other hand, P~4~ was undetected at metestrus and diestrus, owing to its low concentration. Blood was collected from same mice at proestrus and estrus; blood collection at estrus was 24 h following blood collection at proestrus. These results indicate that the concentration of P~4~ in blood of the mouse varies during estrus cycle and pregnancy.

Discussion {#s3}
==========

In this study, we evaluated the effect of P~4~ on follicle growth and ovulation in the mouse ovary and found that the P~4~ effect differed between follicle stages in a concentration-dependent manner ([Figs. 1](#fig_001){ref-type="fig"},[2](#fig_002){ref-type="fig"} and[3](#fig_003){ref-type="fig"}). In the ovary, P~4~ is produced in both follicular and CL cells \[[@r12], [@r30]\]. The concentration of P~4~ in blood regularly changed based on the dynamics of ovarian tissue, follicular development, ovulation, follicle atresia, as well as the formation and atresia of CL during estrus cycles \[[@r29]\]. Previous studies showed that ovulation was disturbed by treatment with PGR antagonist or in mice with mutated PGR \[[@r19], [@r21], [@r23], [@r24]\]. Furthermore, PGR expresses in granulosa cells of Graafian follicles only during periovulatory period \[[@r20]\], suggestive of the regulatory role of P~4~ in ovulation; however, some studies showed that P~4~ affected the growth of developing follicles except Graafian follicles \[[@r31], [@r32]\]. Using immortalized and isolated primary rat granulosa cells, Peluso *et al.* found that P~4~ inhibited both mitosis and apoptosis of granulosa cells \[[@r33], [@r34]\]. While these reports clearly showed that P~4~ controls follicle growth, others address the effect of P~4~ on follicular growth *in vivo* \[[@r35]\]. We aimed to evaluate the effect of P~4~ at each stage of follicle growth *in vivo* using ovarian tissue culture. We used varying P~4~ concentration to reproduce *in vivo* conditions and observed that the effect of P~4~ on follicle growth differs at every follicle stage ([Fig. 2](#fig_002){ref-type="fig"}). P~4~ showed no effect at 10 ng/ml, while it promoted the growth of primordial-primary follicles at 100 ng/ml. At 1 μg/ml, P~4~ suppressed the growth of secondary follicles ([Fig. 2B and F](#fig_002){ref-type="fig"}). These results indicate that the blood concentration of P~4~ coordinates with the follicle growth in the ovary to prepare for the next ovulation. The blood concentration of P~4~ increases together with an LH surge and further increases after ovulation \[[@r29]\]. Based on these changes in blood concentration, P~4~ is thought to promote ovulation and growth of primordial and primary follicles for future ovulation in response to LH surge. Furthermore, at high concentration P~4~ suppressed ovulation and growth of secondary follicles to prepare for fertilization and pregnancy ([Figs. 2](#fig_002){ref-type="fig"} and[3](#fig_003){ref-type="fig"}). Previous reports indicated the change in the concentration of P~4~ in blood of rats, but there is no data available in mice. It is difficult to measure the concentration of P~4~ in the mice, owing to the low volume of blood in mice than in rats. In this experiment, we tried to measure the concentration of P~4~ in 50 μl blood. While P~4~ was detected in blood at proestrus, estrus, and pregnant stage, its concentration at metestrus and diestrus was undetected. These results indicate that the concentration of P~4~ surged during the periovulatory stage and pregnancy ([Fig. 6](#fig_006){ref-type="fig"}). The concentration of P~4~ may be higher than that detected in our study at proestrus and pregnant stage and same as that in rats, as we measured P~4~ level only at one time point at each stage. As blood was withdrawn from the same mouse at proestrus and estrus, the concentration of P~4~ around ovulation must be sustained to be higher level than other stage during mouse estrus cycle. These results show that the concentration of P~4~ in mouse blood varied during the estrus cycle, as reported in rats. The relationship between the blood concentration of P~4~ and results observed in our study is consistent with the physiology of the ovary during the estrus cycle. A previous study reported that intraovarian insertion of a P~4~ implant into monkey ovary suppressed follicle growth \[[@r36]\]. Therefore, the effect of P~4~ on follicle growth may not be exerted directly through blood but through follicles and CLs in the ovary. The follicle environment in the ovary is important for the regulation of follicle growth because P~4~ production is higher in CLs than in follicles and P~4~ production in follicles varies with the follicle stage \[[@r12], [@r30]\]. Therefore, the localization and developmental stage of follicles may determine the growth speed of each follicle. In any case, P~4~ is one of the key factors controlling follicle growth based on the physiological condition of the ovary.

P~4~ is metabolized to estrogens and androgens in follicles of rodents \[[@r37],[@r38],[@r39]\]. Estrogens have some roles in the follicle development \[[@r40], [@r41]\]. We evaluated whether P~4~ was converted into 17β-estradiol in the cultured ovary and studied its ability to bind to receptors on follicles. The treatment with P~4~ failed to alter the concentration of 17β-estradiol ([Fig. 4](#fig_004){ref-type="fig"}), indicating the direct effect of P~4~ on follicle growth through its receptor.

P~4~ transduces signal to granulosa cells through PGR. However, PGR is not expressed in granulosa cells of developing follicles \[[@r42],[@r43],[@r44]\]. A recent study revealed high-level expression of PGRMC1 in granulosa cells of developing follicles \[[@r25]\]. PGRMC1 can transduce the P~4~ signal into granulosa cells \[[@r26]\]. Studies have shown that P~4~ suppresses the proliferation and apoptosis of cultured granulosa cells \[[@r17], [@r34], [@r45]\], consistent with our observation that P~4~ suppressed the growth of secondary follicles at high concentration. However, this is contradictory to our observation that P~4~ promoted the growth of primordial-primary follicle at 100 ng/ml ([Fig. 2B and F](#fig_002){ref-type="fig"}). The contrasting result may be attributed to two factors. First, the effect of P~4~ varied between the granulosa cells from the primordial-primary follicles and secondary follicles. Previous reports used granulosa cells from various follicle stages or large follicles rather than secondary follicles \[[@r46], [@r47]\]. Our result suggests variation in the effect of P~4~ between granulosa cells of the primordial-primary and secondary-antral follicles. Second, the interaction between follicles in the ovary may alter the effect of P~4~. The growth of follicles must be coordinated within the ovary; the interaction between follicles is important in controlling the growth of each follicle. Secondary or antral follicles may influence the effect of P~4~ on primordial-primary follicles. In this case, the actual *in vivo* effect of P~4~ on follicular growth at each stage is not observed in cultured granulosa cells. We observed the expression of PGRMC1 only in a few primordial follicles ([Fig. 5A](#fig_005){ref-type="fig"}). Therefore, P~4~ may mainly promote the growth of primary follicles ([Fig. 2B](#fig_002){ref-type="fig"}).

Our results show that the P~4~ concentration in blood or ovary controls the follicular growth at each stage. The concentration-dependent effect of P~4~ is important for sustaining long-term periodic ovulation. The P~4~-PGRMC1 pathway is thought to be involved in premature ovarian failure \[[@r35]\]. Thus, it is important to understand the regulatory mechanism of follicle growth through the P~4~-PGRMC1 pathway not only in the cultured granulosa cells but also in the ovary containing follicles at various developmental stages, CLs, and other many tissues. Culture methods that mimic the *in vivo* conditions may help us study the effect of factors controlling the follicle growth in the ovary. Our culture method is useful to reveal the regulatory mechanism of the follicle growth in the ovary.
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